- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? ; volume:11 ; number:9 ; day:4 ; month:8 ; year:2020 ; pages:1909-1914 ; date:9.2020
Diabetes therapy ; 11, Heft 9 (4.8.2020), 1909-1914, 9.2020
- Creator
-
Monda, Vincenzo M.
Porcellati, Francesca
Strollo, Felice
Gentile, Sandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-020-00898-8
- URN
-
urn:nbn:de:101:1-2020100921333663956715
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Monda, Vincenzo M.
- Porcellati, Francesca
- Strollo, Felice
- Gentile, Sandro
- SpringerLink (Online service)
Other Objects (12)
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
ACE2: the molecular doorway to SARS-CoV-2
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
ACE2: the molecular doorway to SARS-CoV-2
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
ACE2: the molecular doorway to SARS-CoV-2
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Outsmarting SARS-CoV-2 by empowering a decoy ACE2